Yunlong Pan

No. 601, Huangpu Avenue
Guangzhou, 510632, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

Editorial: Ferroptosis and regulation mechanism in the tumor immune microenvironment for tumor progression and treatment.

Editorial: Ferroptosis and regulation mechanism in the tumor immune microenvironment for tumor progression and treatment.

Journal: Frontiers in immunology

Published: November 17, 2025

Mitigating Cancer Therapy-Related Cognitive Impairment by Targeted Activation of Undruggable Phosphatase.

Mitigating Cancer Therapy-Related Cognitive Impairment by Targeted Activation of Undruggable Phosphatase.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: October 21, 2025

Gamma Knife stereotactic radiotherapy combined with tislelizumab as later-line therapy in pMMR/MSS/MSI-L metastatic colorectal cancer: a phase II trial analysis.

Gamma Knife stereotactic radiotherapy combined with tislelizumab as later-line therapy in pMMR/MSS/MSI-L metastatic colorectal cancer: a phase II trial analysis.

Journal: eLife

Published: June 26, 2025

Phosphorylated NCOA6 promotes aggressiveness and contributes patient outcomes in estrogen receptor-positive breast cancer.

Phosphorylated NCOA6 promotes aggressiveness and contributes patient outcomes in estrogen receptor-positive breast cancer.

Journal: Cancer cell international

Published: April 16, 2025

Targeting SLC7A11 with sorafenib sensitizes stereotactic body radiotherapy in colorectal cancer liver metastasis.

Targeting SLC7A11 with sorafenib sensitizes stereotactic body radiotherapy in colorectal cancer liver metastasis.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Published: January 14, 2025

USP13 Suppresses Colorectal Cancer Angiogenesis by Downregulating VEGFA Expression through Inhibition of the PTEN-AKT Pathway.

USP13 Suppresses Colorectal Cancer Angiogenesis by Downregulating VEGFA Expression through Inhibition of the PTEN-AKT Pathway.

Journal: Oncology research

Published: November 01, 2024

Targeting PLK1-CBX8-GPX4 axis overcomes BRAF/EGFR inhibitor resistance in BRAFV600E colorectal cancer via ferroptosis.

Targeting PLK1-CBX8-GPX4 axis overcomes BRAF/EGFR inhibitor resistance in BRAFV600E colorectal cancer via ferroptosis.

Journal: Nature communications

Published: May 01, 2024

Tissue-resident memory CD103+CD8+ T cells in colorectal cancer: its implication as a prognostic and predictive liver metastasis biomarker.

Tissue-resident memory CD103+CD8+ T cells in colorectal cancer: its implication as a prognostic and predictive liver metastasis biomarker.

Journal: Cancer immunology, immunotherapy : CII

Published: February 08, 2024

Targeting undruggable phosphatase overcomes trastuzumab resistance by inhibiting multi-oncogenic kinases.

Targeting undruggable phosphatase overcomes trastuzumab resistance by inhibiting multi-oncogenic kinases.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Published: January 23, 2024

New findings in prognostic factor assessment for adenocarcinoma of transverse colon: a comparison study between competing-risk and COX regression analysis.

New findings in prognostic factor assessment for adenocarcinoma of transverse colon: a comparison study between competing-risk and COX regression analysis.

Journal: Frontiers in medicine

Published: September 25, 2023

Prediction of death probability in adenocarcinoma of the transverse colon: competing-risk nomograms based on 21,469 patients.

Prediction of death probability in adenocarcinoma of the transverse colon: competing-risk nomograms based on 21,469 patients.

Journal: Journal of cancer research and clinical oncology

Published: April 12, 2023

USP12 promotes nonsmall cell lung cancer progression through deubiquitinating and stabilizing RRM2.

USP12 promotes nonsmall cell lung cancer progression through deubiquitinating and stabilizing RRM2.

Journal: Molecular carcinogenesis

Published: March 18, 2023

Showing 1-12 of 46

Last Updated: 09/26/2026